Inactief instrument

Andere talen Adamas Pharmaceuticals, Inc.

Aandelen

ADMS

US00548A1060

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Adamas Pharmaceuticals : Completion of Acquisition or Disposition of Assets - Form 8-K	24-11-21
ADAMAS PHARMACEUTICALS INC : Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)	24-11-21
Adamas Pharmaceuticals, Inc. Announces Management Changes	24-11-21
Adamas Pharmaceuticals, Inc.(NasdaqGM:ADMS) dropped from NASDAQ Composite Index	24-11-21
Adamas Pharmaceuticals, Inc.(NasdaqGM:ADMS) dropped from S&P TMI Index	24-11-21
Adamas Pharmaceuticals, Inc.(NasdaqGM:ADMS) dropped from S&P Global BMI Index	24-11-21
Supernus Pharmaceuticals, Inc. completed the acquisition of Adamas Pharmaceuticals, Inc. from Mohr Davidow Ventures and others.	24-11-21
Supernus Pharmaceuticals Announces Expiration of Hart-Scott-Rodino Waiting Period for Adamas Pharmaceuticals Tender Offer	23-11-21
Adamas: Q3 Earnings Snapshot	11-11-21
ADAMAS PHARMACEUTICALS INC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	10-11-21
Adamas Pharmaceuticals, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	10-11-21
North American Morning Briefing : Stock Futures -3-	13-10-21
ADAMAS PHARMACEUTICALS INVESTOR ALERT By the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Adamas Pharmaceuticals, Inc. - ADMS	12-10-21
Adamas Pharmaceuticals : Supernus Pharmaceuticals to Acquire Adamas Pharmaceuticals Strengthening its CNS Product Portfolio - Form 8-K	12-10-21
ADAMAS PHARMACEUTICALS INC : Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits (form 8-K)	12-10-21
DJ Industrial : US Stocks Drop Monday as Markets Await Big Bank Earnings; Oil Price Advances	11-10-21
Close Update: US Stocks Reverse Earlier Gains as Markets Await Big Bank Earnings; Oil Price Advances	11-10-21
Flexion Therapeutics : Health Care Stocks Sliding in Late Monday Trading	11-10-21
Adamas Pharmaceuticals : Health Care Stocks Drifting Monday as Biotechs Climb	11-10-21
NASDAQ 100 : Top Midday Gainers	11-10-21

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Adamas Pharmaceuticals, Inc.

Aandelen

ADMS

US00548A1060

Andere talen

Filters